ライフサイエンスコーパス: crossover study

1 BAAR) in a double-blind, placebo-controlled, crossover study.

2 requency to 12 healthy volunteers in a 2 x 2 crossover study.

3 S were included in a randomised, controlled, crossover study.

4 k, phase 4, randomized, investigator-masked, crossover study.

5 were enrolled in a prospective, randomized, crossover study.

6 separate days in a randomized, double-blind, crossover study.

7 -blind, placebo-controlled, counterbalanced, crossover study.

8 completed this 3-week inpatient, randomized, crossover study.

9 eted this four-centre, double-blind, two-way crossover study.

10 Experiment one is a five-session crossover study.

11 3.7 +/- 3.5 y) were included in a randomized crossover study.

12 Thirty-one surgeons were recruited for a crossover study.

13 rticipated in this randomized, subject-blind crossover study.

14 omized, double-blind, placebo-controlled 3x3 crossover study.

15 corrected, double-blind, placebo-controlled, crossover study.

16 ed, double-blind, placebo-controlled, triple-crossover study.

17 IU) or placebo in a double-blind, randomized crossover study.

18 e studied in this randomized, double-blinded crossover study.

19 in a randomized placebo-controlled three-way crossover study.

20 were enrolled in a 3-period, 7-wk randomized crossover study.

21 ach for 6 weeks in a randomized double-blind crossover study.

22 clonidine, and paroxetine) in a double-blind crossover study.

23 utput in a double-blind, placebo-controlled, crossover study.

24 ) participated in a randomized, double-blind crossover study.

25 icipated in a randomized, placebo-controlled crossover study.

26 andomized, double-blind, placebo-controlled, crossover study.

27 ted in a single-blinded, randomized, 2-phase crossover study.

28 placebo-controlled, randomized, double-blind crossover study.

29 s part of a double-blind, placebo-controlled crossover study.

30 /- 0.6 g/dl) were studied in this randomized crossover study.

31 abetes in a randomized, single-blind, triple-crossover study.

32 -htrA in a double-blind, placebo-controlled, crossover study.

33 (10)]) or air in a double-blind, randomized, crossover study.

34 ram) to placebo in a randomized double-blind crossover study.

35 double blind, placebo-controlled, two-period crossover study.

36 0.5 N saline in a double-blind, randomized, crossover study.

37 hma completed this double-blind, four-period crossover study.

38 consumed on sequential days in a randomized crossover study.

39 sly over 4 hours via pump in this randomized crossover study.

40 obtained through an isotopic double-labeling crossover study.

41 rdia syndrome in a randomized, single-blind, crossover study.

42 a two-drug, placebo-controlled, double-blind crossover study.

43 n; 191.9 +/- 9.9 kcal added) in a randomized crossover study.

44 asked crossover design and 1 with 4 parallel crossover studies.

45 Both were randomized, double-blind, crossover studies.

46 ed in this placebo-controlled, double-blind, crossover study (0.5 mg/kg cortisol or intravenous place

47 In a single-blind, randomized, crossover study, 10 insulin-resistant men consumed 3 hig

48 In a randomized, double-blinded crossover study, 10 overweight or obese volunteers witho

49 In a randomized, double-blind, crossover study, 10 postmenopausal women without additio

50 In our human crossover study, 11 healthy subjects were studied under

51 In a 2-day, double-blind crossover study, 11 lean and 11 obese healthy women unde

52 In this multicenter, double-blind, crossover study, 110 patients with heart failure and a p

53 In a randomized, single-blinded crossover study, 12 healthy white men [mean age: 24 y; B

54 andomized, double-blind, placebo-controlled, crossover study, 12 healthy, young males received gonado

55 In a randomized crossover study, 13 volunteers consumed fresh and fermen

56 In this double-blind, randomized crossover study, 14 men aged 20-31 y were fed low-zinc a

57 In a randomized crossover study, 14 patients with OSA attended two sleep

58 genous pathway.In a randomized, double-blind crossover study, 16 healthy individuals were supplemente

59 In a controlled crossover study, 16 healthy iron-replete volunteers unde

60 In this single-blind, placebo-controlled crossover study, 16 participants completed two study day

61 diet for 100 d) and to human volunteers in a crossover study (180 g/d for 4 d).

62 In an open-label randomized crossover study, 19 healthy firefighters (age, 41+/-7 ye

63 randomized, double-blind placebo-controlled crossover study, 19 patients with mild-to-moderate idiop

64 In a double-blind, randomized, crossover study, 20 men with prior myocardial infarction

65 In a randomized, double-blind, crossover study, 20 patients with major depression were

66 genotype-stratified, double-blind, four-way crossover study, 21 healthy adult subjects were exposed

67 In this crossover study, 3- to 5-y-old children (n = 10 boys, 16

68 In the crossover study, 31 healthy volunteers completed two ran

69 In a multicenter, randomized, open-label, crossover study, 34 blacks with stable CAD receiving ace

70 In this dose-escalating, crossover study, 34 healthy men received a 6-h double-bl

71 In a randomized, 2-way crossover study, 39 healthy men consumed a meal that con

72 on instructions; (3) an adequately conducted crossover study; (4) comparison of equivalent doses; (5)

73 In this single-blind case-crossover study, 41 healthy subjects underwent an extens

74 In a double-blind, placebo-controlled, crossover study, 44 elderly subjects were randomly assig

75 In this crossover study, 45 male patients with coronary artery d

76 a prospective, single-center, single-blind, crossover study, 56 patients with non-ST-elevation acute

77 In a blinded, 2-cycle, crossover study, 59 platelet donors were randomized to r

78 acebo-controlled, multiple-dose, 2-sequence, crossover study, 64 patients were randomized to receive

79 s in a randomized, double-blind manner, with crossover studies 7 to 10 days later.

80 This double-blind, randomized crossover study addressed the impact of daily stressors

81 9% predicted) in a double blind, randomized, crossover study after aerosolization of a single dose of

82 This randomized, blinded crossover study aimed to document if stimulation at 75%

83 A crossover study analysis was done on the 259 patients wh

84 on is proposed in detail and is supported by crossover studies and a number of unambiguous experiment

85 time and with published data and the use of crossover studies and adjustment equations to ensure com

86 d, double-blind, placebo-controlled, two-way crossover studies and an open study in nonallergic subje

87 randomized, placebo-controlled, single-blind crossover study and compared with 12 healthy, nonobese c

88 pated in a double-blind, placebo-controlled, crossover study and inhaled single doses of fluticasone

89 s, including Hammett plots, Eyring analysis, crossover studies, and investigations of the influence o

90 used include multiple-arm trials, randomized crossover studies, and more compromised designs such as

91 ional Poisson regression analysis and a case-crossover study approach.

92 A placebo-controlled crossover study assessed the opioid pharmacodynamic prof

93 ouble-blind, randomised, placebo-controlled, crossover study at 24 sites in North America and Europe.

94 d, double-blind, placebo-controlled 2-period crossover study at 7 neuromuscular referral centers in 4

95 ouble-blind, placebo-controlled, two-period, crossover study at one UK centre.

96 n-label, multicentre, randomised controlled, crossover study between Dec 1, 2012, and Dec 23, 2014, r

97 the meta-analysis was limited to randomized crossover studies, both systolic [1.3 (-0.3, 2.9) mm Hg;

98 This open-label, dose-ranging, crossover study (COMPACT Phase II) was conducted in 18 p

99 A randomized crossover study compared the effects of a statin (ceriva

100 This double-blind randomized crossover study compared the impact of 4 wk of supplemen

101 Randomized or crossover studies comparing antianginal drugs from 2 or

102 med a randomized, double-blind, single-dose, crossover study comparing 0.5 mg/kg MPH with 1.0 mg/kg A

103 s for bleeding in a prospective, randomized, crossover study comparing 6 months of anti-inhibitor coa

104 rticipated in this randomized, double-blind, crossover study comparing a single dose of NO3-rich beet

105 An initial crossover study comparing dual- and single-site right at

106 We performed an open-label, randomized, crossover study comparing overnight closed-loop therapy

107 pen-label, expanded safety and acceptability crossover study comparing rectally applied reduced-glyce

108 We conducted a randomized, crossover study comparing selective heart rate reduction

109 ans, we performed a randomized, double-blind crossover study comparing the calcium antagonist amlodip

110 double-blind, randomized, placebo-controlled crossover study comparing the effect of the bradykinin B

111 ucted a randomized, multicenter, open-label, crossover study comparing the efficacy and safety of a 1

112 adults underwent a randomized, double-blind, crossover study comparing the vascular response to the 2

113 ion-level exposure time trends can bias case-crossover studies conducted among "first-wave" users of

114 ESIGN, SETTING, AND PARTICIPANTS: Randomized crossover study conducted between January 1 and December

115 zed, controlled, examiner-blind, nine-period crossover study conducted in 72 adult subjects over a 3-

116 This case-crossover study, conducted between July 2007 and May 200

117 y-seven patients on hemodialysis completed a crossover study consisting of two exercise training phas

118 In a randomized crossover study, cynomolgus monkeys were fed either a co

119 A randomized, double-blind, 5-period crossover study design (n = 22) was used to examine the

120 We used a time-stratified case-crossover study design and conditional logistic regressi

121 We used the case-crossover study design to compare the reported use of ma

122 A case-crossover study design was used to analyze ischemic even

123 A case-crossover study design was used to investigate associati

124 A randomized, controlled, 3-diet, 3-period crossover study design was used.

125 andomized, controlled three-period (ABB/BAA) crossover study design was used.

126 A time-stratified case-crossover study design was used.

127 A crossover study design was used: the bion was on for the

128 Using a double-blind, randomized crossover study design, 24 healthy volunteers completed

129 nd pacing backup (AAI-30) in a double-blind, crossover study design, followed by an uncontrolled and

130 Using a time-stratified case-crossover study design, we found a 10.4% change (95% con

131 ing a prospective, randomized, single-blind, crossover study design, we therefore measured EE and rat

132 eve catecholamine depletion in a randomized, crossover study design.

133 ts and ER visits for GI illness using a case-crossover study design.

134 randomized, double-blind, placebo-controlled crossover study design.

135 self-matched control data based on the case-crossover study design.

136 ropriate number of subjects for parallel and crossover study designs.

137 A prospective, randomized crossover study directly comparing blood culture contami

138 double-blind, placebo-controlled, randomized crossover study, disease-free patients at least 1 year p

139 In a crossover study done in medical centres in France, Italy

140 es from 14 mildly hypertensive patients in a crossover study during a high-sodium (HS, 160 mmol/d) di

141 ght adolescents participated in a randomized crossover study during which EAH was measured as intake

142 Thereafter, in a randomized crossover study, each participant performed a patient-sp

143 e-center, double-masked, placebo-controlled, crossover study evaluated the efficacy of 8 weeks of tre

144 a randomized, double-blind, ascending-dose, crossover study evaluating 3 doses of BG9719 in 63 patie

145 double-blind, randomized, placebo-controlled crossover study evaluating the effect of 14 days of XEN-

146 Randomized, double-blind, crossover study evaluating twice daily fluticasone propi

147 ed, controlled, examiner-masked, five-period crossover study examined plaque removal in 25 subjects f

148 This randomized crossover study examined whether EAA supplementation wit

149 The present within-subject crossover study examines the variability in individual r

150 A randomized crossover study explored whether viewing different scene

151 Extensive double-labeling crossover studies have been conducted.

152 We undertook three randomised crossover studies in 19 patients aged 5-18 years with ty

153 We did a double-blind, randomised, crossover study in 11 patients with asthma and 13 matche

154 randomized, double-blind, placebo-controlled crossover study in 14 nondiabetic overweight or obese (b

155 a randomized double-blind placebo-controlled crossover study in 16 men, with measurement of liver 11b

156 andomized, double-blind, placebo-controlled, crossover study in 21 PD patients on levodopa but no ago

157 randomized, placebo-controlled, four-period, crossover study in 24 patients with T2D, dipeptidyl pept

158 ducted a randomized, double-blind, three-way crossover study in 27 patients with proteinuric CKD to c

159 ouble-blind, randomised, placebo-controlled, crossover study in a hospital and two infirmaries in the

160 In a randomized crossover study in a metabolic unit, 15 young adults wer

161 This was a prospective randomized crossover study in nonintubated patients with AHRF with

162 We conducted a case-crossover study in Ontario, Canada between 2004 and 2011

163 In this blinded, 3-period, crossover study in stable patients with coronary artery

164 attacks by conducting an internet-based case-crossover study in the United States (in 2003-2010) amon

165 75 mg in a 3-period (12 days each) blinded, crossover study in VE (n = 73; mean: 79 +/- 3 years of a

166 We did a random-order crossover study in volunteers at least 18 years old who

167 We performed a randomized double-blind crossover study in which 32 healthy adults (25.9 +/- 6.6

168 t hoc analysis of the data is functionally a crossover study in which only surviving patients can cro

169 ng men participated in a randomized 3 x 2-wk crossover study in which the following 3 isocaloric diet

170 completed a double-blind, placebo-controlled crossover study in which they received 2 daily subcutane

171 This case-crossover study included 27,540 adults with RD from Fren

172 double-blind, randomized, placebo-controlled crossover study included 44 CF patients (aged 7-19 y; 20

173 This double-blind, randomized, crossover study included serial assessments of resting e

174 nalyzed data from 13 double-blind randomized crossover studies including 282 participants (140 health

175 Case-crossover studies investigating the association between

176 A 5-year natural experimental crossover study involving patients admitted to four ICUs

177 We performed a crossover study involving seven totally blind subjects w

178 ouble-blind, randomized, placebo-controlled, crossover study, LSD (200 mug) and placebo were administ

179 Crossover studies (m-->F, f-->M) demonstrated that enhan

180 In the crossover study, mean removal rate was 94.6% (SD = 6.5%)

181 9), randomized clinical trials (n = 9), and crossover studies (n = 5).

182 DESIGN, SETTING, AND PARTICIPANTS: A case-crossover study nested within a prospective cohort study

183 In a double-blind, randomised crossover study, nine healthy subjects completed knee-ex

184 In case-crossover studies of medications, contamination by persi

185 iculate matter (</=2.5 micro m) using a case-crossover study of 1,206 Washington State out-of-hospita

186 e-center, randomized, double-blind, 3-period crossover study of 11 women with IBS (35.50 +/- 12.48 ye

187 new study model, we performed a randomized, crossover study of 12 adult asthmatics who required 800

188 In a single-blinded and placebo-controlled crossover study of 15 healthy participants, we administe

189 EMENTS: In a randomized, placebo-controlled, crossover study of 192 subjects with moderate asthma, we

190 The authors examined this question in a case-crossover study of 20 US cities.

191 We did a nested cohort crossover study of 28 participants in the PUVA follow-up

192 , AND PARTICIPANTS: Prospective, nested case-crossover study of 288 cases of sudden cardiac death wit

193 age, 62 +/- 7 years) completed a, randomized crossover study of 4 weeks of both low (DSR) and normal

194 e, and substrate metabolism in a prospective crossover study of 4-month duration, consisting of four

195 llen Children and Adolescent study is a case-crossover study of 644 children and adolescents (aged 2-

196 dication and serious fall injuries in a case-crossover study of 90 127 Medicare beneficiaries who wer

197 A pragmatic cluster randomized, crossover study of 9340 patients admitted to 5 adult int

198 andomized, double-blind, placebo-controlled, crossover study of Adderall in 27 well-characterized adu

199 In this short-term, crossover study of adolescents with newly diagnosed hype

200 A time-stratified case-crossover study of ambient ozone exposure and emergency

201 A double-blind, placebo-controlled crossover study of caloric deprivation was conduced in a

202 e performed a randomized, placebo-controlled crossover study of CRF compared with saline injection in

203 ble-blinded, randomized, placebo-controlled, crossover study of DBS targeting the ventral striatum/an

204 A randomized, blinded, placebo-controlled crossover study of either 0.5 mg neostigmine or saline (

205 A randomized, open-label, 2-period, crossover study of healthy subjects (n = 160, age 18 to

206 randomized, double-blind, placebo-controlled crossover study of individuals with self-reported non-ce

207 centre, placebo-controlled, double-blind 2x2 crossover study of ivacaftor treatment was conducted in

208 ble-blind, double-dummy, placebo-controlled, crossover study of objectively assessed nonsmokers (n =

209 nd, placebo-controlled, randomized, 3-period crossover study of OPC-28326 (oral doses of 10 mg or 40

210 conducted a multi-site time-stratified case-crossover study of ozone exposures for approximately 3.7

211 44) was a randomized, double-blind, 2-phase crossover study of prasugrel compared with high-dose clo

212 Patients were randomized in a crossover study of pravastatin and simvastatin.

213 his was a randomized, double-blind, 12-week, crossover study of rosuvastatin 20 mg versus placebo, fo

214 study was nested within a cluster-randomized crossover study of selective digestive decontamination a

215 e randomized into a double-blind four-period crossover study of sustained-release ranolazine 500, 1,0

216 A case-crossover study of Swedish cases was conducted to ascert

217 onducted a double-blind, placebo-controlled, crossover study of the effect of the long-acting beta(2)

218 completed a double-blind, placebo-controlled crossover study of the effects of a single dose of amphe

219 al research sites in an open label, 3-period crossover study of three different daily tenofovir regim

220 al dysfunction were enrolled in a randomized crossover study of transfusing autologous, leukoreduced

221 andomized, double-blind, placebo-controlled, crossover study of two weeks of losartan (50 mg q.d.) on

222 double-blind, randomized, placebo-controlled crossover study of UDCA in 17 clinically stable male pat

223 randomized, placebo-controlled, double-blind crossover study on 10 patients with NYHA class II to III

224 randomized, placebo-controlled, double-blind crossover study on 11 patients with New York Heart Assoc

225 zed, double blind, placebo-controlled, 2-way crossover study on 20 subjects with asthma comparing the

226 tain an intervention group of interest, were crossover studies, or were only published in abstract fo

227 d, double-blind, placebo-controlled, partial-crossover study, participants aged 18 to 65 years with a

228 In this investigator-masked, crossover study, patients with unmet target intraocular

229 , SETTING, AND PARTICIPANTS: A single-blind, crossover study, performed in a hypobaric chamber, to as

230 Crossover study sample size calculations using these rat

231 In this double blind crossover study, shifts in circulating levels of n-3 and

232 The case-crossover study showed a statistically significant inver

233 A recent randomized, controlled, crossover study showed that effective treatment of OSA w

234 In this double-blind crossover study, subanorectic doses of each peptide alon

235 In the chronic crossover study, subjects with coronary heart disease co

236 Study 2 was a randomized crossover study that compared 4 diets in 30 volunteers w

237 c-dose study was a randomised, double-blind, crossover study that enrolled adults (aged >/=18 years)

238 In a randomized, double-blind crossover study, the cysteinyl leukotriene antagonist mo

239 In conclusion, in this randomized, crossover study, there was no significant difference in

240 We conducted two placebo-controlled crossover studies to assess the bronchodilator response

241 cohort study and 2 interventional randomized crossover studies to assess: 1) the relationship between

242 lthy volunteers were exposed in a randomized crossover study to 0.3 ppm ozone and clean air for 2 hr

243 lled in a double-blinded, placebo-controlled crossover study to assess the effect of 1200 mg of gamma

244 were enrolled in a bicentric intraindividual crossover study to compare lesion enhancement with doses

245 lind placebo-controlled randomized three-way crossover study to compare the hemodynamic effects of 7

246 We conducted a case-crossover study to compare the rates of antipsychotic us

247 blind, randomized, placebo-controlled, 2-way crossover study to determine the reversal effect of desc

248 We conducted a case-crossover study to evaluate the relationship between air

249 We conducted a case-crossover study to examine the associations of a set of

250 ouble-blind, randomized, placebo-controlled, crossover study to follow spirometry, quality of life qu

251 -period, double-blind, balanced Latin square crossover study to receive placebo, and ranolazine 500,

252 In this randomized, double-blind, crossover study, twelve normoglycaemic men (BMI 25-35 kg

253 We performed a cohort-crossover study using data on all emergency department v

254 andomized, double-blind, placebo-controlled, crossover study using functional magnetic resonance imag

255 A case-crossover study utilizing time-stratified controls was c

256 A randomized controlled crossover study was conducted in 12 patients with modera

257 A single-blind, randomized, crossover study was conducted in 30 men and 30 women (30

258 d, double-blind, placebo-controlled, two-way crossover study was conducted in 35 male subjects allerg

259 A case-crossover study was conducted in 36 US cities to evaluat

260 andomized, double-blind, placebo-controlled, crossover study was conducted in 80 patients with CAD, c

261 le-blind, placebo-controlled, within-subject crossover study was conducted in healthy adults (n=17).

262 , double-blind, placebo-controlled, 2-period crossover study was conducted with the Vienna Challenge

263 A case-crossover study was conducted.

264 andomized, double-blind, placebo-controlled, crossover study was designed to determine the safety and

265 This double blind, Sham-controlled, crossover study was designed to test the hypothesis that

266 A double-blinded, placebo-controlled, crossover study was employed to determine the renal resp

267 ameters in a single-blind placebo-controlled crossover study was investigated.

268 Subsequently, a crossover study was performed by randomly assigning anot

269 A randomized, controlled, crossover study was performed in 15 healthy volunteers w

270 d, double-blind, placebo-controlled, two-way crossover study was performed in 22 steroid-naive mild-t

271 A 3-arm, 12-d randomized crossover study was performed in 30 men and 28 women [me

272 A 12-d randomized crossover study was performed in 40 men and 39 women [me

273 A crossover study was then done in which levodopa-treated

274 se of this double-blind, placebo-controlled, crossover study was to determine age-related differences

275 The aim of this randomized, crossover study was to determine if transoral fundoplica

276 rpose of this sham-controlled, double-blind, crossover study was to identify the neural circuitry tha

277 A randomized crossover study was undertaken with 47 overweight and ob

278 In a randomized, crossover study, we assigned 13 patients with type 2 dia

279 In a crossover study, we assigned 28 participants to outdoor

280 In a prospective crossover study, we enrolled 33 patients with ischemic c

281 In this randomised, open-label, crossover study, we enrolled preadolescent children (age

282 In this case-crossover study, we included the 1316 patients who recei

283 In a double-blind, 3-period crossover study, we randomly assigned 28 healthy postmen

284 In this open-label, randomised, crossover study, we recruited adults (aged >/=18 years)

285 In this randomised, crossover study, we recruited men and women aged 60 year

286 Here, in a 6-month double-blind alternating crossover study, we show that bilateral deep brain elect

287 Two crossover studies were conducted: 36 participants with t

288 Crossover studies were performed 7 to 10 days apart.

289 andomized, placebo-controlled, double-blind, crossover studies were performed for 1 month on patients

290 Two double-blind, 4-way crossover studies were performed, each of which included

291 es unbiased health-effects estimates in case-crossover studies with shared exposures.

292 In two random-order, crossover studies with similar but distinct designs, we

293 In a crossover study with 7 healthy volunteers, 2 experiments

294 We designed an open-label, randomized, crossover study with blind end point evaluation to compa

295 In this prospective, randomized, open-label crossover study with masked outcome assessments, stable

296 performed a randomized, placebo-controlled, crossover study with prednisolone (40 mg daily) or place

297 randomized, double-blind, placebo-controlled crossover study with single-dose intranasal oxytocin (24

298 healthy men were studied in a single-blind, crossover study with two randomized visits (one with 40

299 ere studied in a randomized, double-blinded, crossover study, with 2-h intravenous administration of

300 Furthermore, in a double-blind, randomized, crossover study, xylitol sprayed for 4 days into each no